ISENTRESS (H.J. Harkins Company Inc.)


Welcome to the PulseAid listing for the ISENTRESS drug offered from H.J. Harkins Company Inc.. This HIV Integrase Inhibitors [MoA],Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: H.J. Harkins Company Inc.
NON-PROPRIETARY NAME: RALTEGRAVIR
SUBSTANCE NAME: RALTEGRAVIR POTASSIUM
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: HIV Integrase Inhibitors [MoA],Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2017-07-31
END MARKETING DATE: 0000-00-00


ISENTRESS HUMAN PRESCRIPTION DRUG Details:

Item DescriptionISENTRESS from H.J. Harkins Company Inc.
LABELER NAME: H.J. Harkins Company Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 400(mg/1)
START MARKETING DATE: 2017-07-31
END MARKETING DATE: 0000-00-00
PRODUCT ID: 76519-1130_5554d179-32de-531e-e054-00144ff8d46c
PRODUCT NDC: 76519-1130
APPLICATION NUMBER: NDA022145

Other RALTEGRAVIR POTASSIUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Avera McKennan HospitalISENTRESS
DIRECT RXISENTRESS
Dispensing Solutions, Inc.ISENTRESS
H.J. Harkins Company Inc.ISENTRESS
Merck Sharp & Dohme Corp.ISENTRESS
NuCare Pharmaceuticals,Inc.ISENTRESS
Physicians Total Care, Inc.ISENTRESS
RedPharm Drug, Inc.ISENTRESS
REMEDYREPACK INC.ISENTRESS
State of Florida DOH Central PharmacyISENTRESS